Repare Therapeutics Inc. Operating Cash Flow
Repare Therapeutics Inc. reported Operating Cash Flow of -$42.82 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-14
- Repare Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $2.65M.
- Repare Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$16.34M.
- Repare Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$29.13M, a 344.16% decline year-over-year.
- Repare Therapeutics Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$27.32M.
- Repare Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$76.44M.
- Repare Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$127.16M, a 39590.06% decline from fiscal 2022.
- Repare Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2022 was $322.00K.
- Repare Therapeutics Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$85.80M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-09-30 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$13.69M derived: sum of 2 quarters · filed 2025-11-14 | -$42.82M 10-Q · filed 2025-11-14 | -$70.15M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | -$16.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$45.48M 10-Q · filed 2025-08-08 | -$72.80M derived: sum of 3 quarters · filed 2025-08-08 | -$103.34M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | -$29.13M 10-Q · filed 2025-05-13 | -$56.46M derived: sum of 2 quarters · filed 2025-05-13 | -$87.00M derived: sum of 3 quarters · filed 2025-11-14 | -$117.51M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | -$27.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$57.86M derived: sum of 2 quarters · filed 2025-11-14 | -$88.38M derived: sum of 3 quarters · filed 2025-11-14 | -$76.44M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$30.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$61.05M derived: sum of 2 quarters · filed 2025-11-14 | -$49.12M 10-Q · filed 2025-11-14 | -$77.28M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$30.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$18.58M 10-Q · filed 2025-08-08 | -$46.74M derived: sum of 3 quarters · filed 2025-08-08 | -$79.61M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $11.93M 10-Q · filed 2025-05-13 | -$16.22M derived: sum of 2 quarters · filed 2025-05-13 | -$49.09M derived: sum of 3 quarters · filed 2025-05-13 | -$83.44M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$28.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$61.03M derived: sum of 2 quarters · filed 2025-03-03 | -$95.37M derived: sum of 3 quarters · filed 2025-03-03 | -$127.16M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$32.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$67.22M derived: sum of 2 quarters · filed 2024-11-07 | -$99.00M 10-Q · filed 2024-11-07 | -$128.64M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$34.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$66.13M 10-Q · filed 2024-08-06 | -$95.77M derived: sum of 3 quarters · filed 2024-08-06 | -$7.61M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$31.79M 10-Q · filed 2024-05-07 | -$61.42M derived: sum of 2 quarters · filed 2024-05-07 | $26.73M derived: sum of 3 quarters · filed 2024-05-07 | -$1.46M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$29.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $58.52M derived: sum of 2 quarters · filed 2024-02-28 | $30.33M derived: sum of 3 quarters · filed 2024-02-28 | $322.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $88.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $59.97M derived: sum of 2 quarters · filed 2023-11-09 | $29.96M 10-Q · filed 2023-11-09 | $9.22M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$28.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$58.20M 10-Q · filed 2023-08-09 | -$78.94M derived: sum of 3 quarters · filed 2023-08-09 | -$111.71M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$30.01M 10-Q · filed 2023-05-09 | -$50.74M derived: sum of 2 quarters · filed 2023-05-09 | -$83.52M derived: sum of 3 quarters · filed 2023-05-09 | -$101.58M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$20.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$53.51M derived: sum of 2 quarters · filed 2023-02-28 | -$71.57M derived: sum of 3 quarters · filed 2023-02-28 | -$85.80M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$32.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$50.83M derived: sum of 2 quarters · filed 2022-11-09 | -$65.06M 10-Q · filed 2022-11-09 | -$78.00M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$18.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$32.28M 10-Q · filed 2022-08-04 | -$45.23M derived: sum of 3 quarters · filed 2022-08-04 | -$65.34M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$14.23M 10-Q · filed 2022-05-05 | -$27.17M derived: sum of 2 quarters · filed 2022-05-05 | -$47.28M derived: sum of 3 quarters · filed 2022-05-05 | -$10.59M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$12.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$33.05M derived: sum of 2 quarters · filed 2022-03-01 | $3.63M derived: sum of 3 quarters · filed 2022-03-01 | -$6.08M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$20.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $16.58M derived: sum of 2 quarters · filed 2021-11-10 | $6.86M 10-Q · filed 2021-11-10 | -$2.48M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $36.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $26.97M 10-Q · filed 2021-08-12 | $17.62M derived: sum of 3 quarters · filed 2022-03-01 | $11.77M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$9.72M 10-Q · filed 2021-05-13 | -$19.06M derived: sum of 2 quarters · filed 2022-03-01 | -$24.91M derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$9.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$15.20M derived: sum of 2 quarters · filed 2022-03-01 | -$18.43M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$5.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$9.08M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$3.23M 10-Q · filed 2020-08-13 |